Key result
Serelaxin dose-dependently attenuated germinal matrix hemorrhage-induced developmental delay, reduced white matter loss, and improved cognitive functions in neonatal rats.
Why the study?
Germinal matrix hemorrhage is a detrimental neonatal CNS injury where inflammation follows eNOS inhibition, prompting investigation of whether Serelaxin activates eNOS and attenuates post-GMH inflammation and brain injury.
Does Serelaxin improve developmental delay, cognitive functions, and brain injury in neonatal rats after germinal matrix hemorrhage?
Does Serelaxin improve developmental delay, cognitive functions, and brain injury in neonatal rats after germinal matrix hemorrhage?
In a neonatal rat model of germinal matrix hemorrhage, Serelaxin attenuated developmental delay, protected the brain, and improved cognitive functions by ameliorating eNOS inhibition and decreasing inflammation.
Answers are grounded in this paper and cite their sources.
Serelaxin shows promise in a neonatal rat model; leaves open translation to human infants with germinal matrix hemorrhage.
Germinal matrix hemorrhage (GMH) is a detrimental form of neonatal CNS injury. Following GMH-mediated eNOS inhibition, inflammation arises, contributing to GMH-induced brain injury. We investigated the beneficial effects of Serelaxin, a clinical tested recombinant Relaxin-2 protein, on brain injury after GMH in rats. We investigated whether effects of Serelaxin are mediated by its ability to activate the GMH-suppressed eNOS pathway resulting in attenuation of inflammatory marker overproduction. GMH was induced by intraparenchymal injection of bacterial collagenase (0.3U). Seven day old Sprague-Dawley rat pups (P7) were used (n = 63). GMH animals were divided in vehicle or serelaxin treated (3 µg once, 30 µg once, 30 µg multiple, i.p., starting 30 after GMH and then daily). Sham operated animals were used. We monitored the developmental profile working memory and spatial function (T-maze and open field test respectively). At day 28, all rats underwent MRI-scans for assessment of changes in cortical thickness and white matter loss. Effects of Serelaxin on eNOS pathway activation and post-GMH inflammation were evaluated. We demonstrated that Serelaxin dose-dependently attenuated GMH-induced developmental delay, protected brain and improved cognitive functions of rats after GMH. That was associated with the decreased post-GMH inflammation, mediated at least partly by amelioration of GMH-induced eNOS inhibition.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2020) studied Germinal matrix hemorrhage (n=87). Serelaxin vs. Vehicle (sterile saline) or sham surgery was evaluated on Developmental delay, white matter loss, and cognitive functions (p=<0.05). Serelaxin dose-dependently attenuated germinal matrix hemorrhage-induced developmental delay, reduced white matter loss, and improved cognitive functions in neonatal rats.
Synapse has enriched 10 related papers. Consider them for comparative context: